Back

Risks of antihypertensive treatment use in different periods of pregnancy

29 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Women's cardiovascular disease and pregnancy Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Jan Vaclavik

University Hospital Ostrava, Ostrava (Czechia)

6 More presentations in this session

Presentation thumbnail
Risk factors and prediction model for hypertension in women with hyperandrogenic phenotypes of polycystic ovary syndrome
Doctor A. Stevanovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Empagliflozin significantly reduces the capacity of sera to induce endothelial dysfunction in Ischemia Non-Obstructive Coronary Arteries (INOCA): EMbArk phase II pilot trial
Doctor O. Quesada (Cincinnati, US)
Abstract Slides Video
Presentation thumbnail
Sex differences in trajectory of left ventricular reverse remodelling under contemporary GDMT in recent-onset dilated cardiomyopathy
Doctor Z. Yang (Chengdu - Sichuan, CN)
Abstract Slides Video
Presentation thumbnail
Improving hypertension management in Egyptian women through standardised nurse training on blood pressure measurement
Professor R. Hany Ibrahim (Cairo, EG)
Abstract Slides Video
Presentation thumbnail
Exploring the relationship between testosterone and cardiovascular disease in women
Doctor S. Alexander (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Women's cardiovascular disease and pregnancy

The Event

Event poster

ESC Congress 2025

29 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Antihypertensive treatment during pregnancy and maternal and fetal outcomes
thumbnail
Congress Presentation
Maternal and fetal outcomes of various lipid-lowering treatment regimens during pregnancy: insights from the czech national registry 2012-2023
thumbnail
Congress Presentation
ACE inhibitor and angiotensin receptor blocker use during pregnancy: data from the ESC Registry of pregnancy and cardiac disease (ROPAC)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources